Literature DB >> 10897337

Selective genetic analysis of p53 immunostain positive cells.

M Phelps1, B S Wilkins, D B Jones.   

Abstract

The isolation of p53 immunostain positive cells from histological sections for molecular genetic studies is a difficult task, especially if there are few positive cells. To eliminate contaminating DNA from p53 negative cells, which can obscure the results of molecular assays, a variation on the technique of immunohistoselective sequencing was developed. This is a highly selective approach, whereby immunostained sections of formalin fixed, paraffin wax embedded tissue are exposed to ultraviolet irradiation to damage the DNA in p53 negative cells. The DNA in positive cells remains unaffected because the dark immunostain protects their nuclei from ultraviolet light. Polymerase chain reaction single strand conformation polymorphism of samples enriched with p53 immunostain positive cells has shown that this method can produce pure samples of mutated DNA. The isolation of DNA from minority immunostain positive cells allows a wide range of molecular analyses to be carried out on these samples, which would otherwise be hampered by the problem of contaminating background cells.

Entities:  

Mesh:

Year:  2000        PMID: 10897337      PMCID: PMC1186924          DOI: 10.1136/mp.53.3.159

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  9 in total

1.  Specific genetic analysis of microscopic tissue after selective ultraviolet radiation fractionation and the polymerase chain reaction.

Authors:  D Shibata; D Hawes; Z H Li; A M Hernandez; C H Spruck; P W Nichols
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

2.  Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications.

Authors:  Q Chou; M Russell; D E Birch; J Raymond; W Bloch
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

3.  Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies.

Authors:  E C Cuevas; A C Bateman; B S Wilkins; P A Johnson; J H Williams; A H Lee; D B Jones; D H Wright
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

4.  Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections.

Authors:  C A Moskaluk; S E Kern
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

5.  Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.

Authors:  S J Meltzer; J Yin; Y Huang; T K McDaniel; C Newkirk; O Iseri; B Vogelstein; J H Resau
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

6.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Authors:  G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

7.  Immunohistoselective sequencing (IHSS) of p53 tumor suppressor gene in human oesophageal precancerous lesions.

Authors:  S T Shi; B Feng; G Y Yang; L D Wang; C S Yang
Journal:  Carcinogenesis       Date:  1996-10       Impact factor: 4.944

8.  Sample preparation and PCR amplification from paraffin-embedded tissues.

Authors:  C E Greer; C M Wheeler; M M Manos
Journal:  PCR Methods Appl       Date:  1994-06

9.  p53 mutation is a common genetic event in ovarian carcinoma.

Authors:  B J Milner; L A Allan; D M Eccles; H C Kitchener; R C Leonard; K F Kelly; D E Parkin; N E Haites
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.